Mortgage Blog

Mirum’s on the hunt for more drugs as $445M Travere deal shows early results

A clinical trial is good news for patients with the rare disease CTX—and for Mirum investors.

Previous Penn researchers Drew Weissman and Katalin Karikó win Nobel Prize for contributions to Covid-19 vaccines
Next With closure of Vechos restaurant, changes are in the works at Granite Bay's Quarry Ponds Town Center

Related Posts

Suggested Posts